DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men
about
Omega-3s and cardiovascular health.Role of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and HumansPolyunsaturated Fatty Acid (PUFA) Status in Pregnant Women: Associations with Sleep Quality, Inflammation, and Length of GestationAnti-Inflammatory Effects of the Mediterranean Diet in the Early and Late Stages of Atheroma Plaque Development.Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik EskimosEffect of eicosapentaenoic acids-rich fish oil supplementation on motor nerve function after eccentric contractions.Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults.Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial.Free Fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage.The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatmentThe evidence for α-linolenic acid and cardiovascular disease benefits: Comparisons with eicosapentaenoic acid and docosahexaenoic acid.DHA concentration of red blood cells is inversely associated with markers of lipid peroxidation in men taking DHA supplement.Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults.Omega-3 fatty acids EPA and DHA: health benefits throughout life.Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factorsMembrane level of omega-3 docosahexaenoic acid is associated with severity of obstructive sleep apnea.Update on the management of severe hypertriglyceridemia--focus on free fatty acid forms of omega-3.Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndromeAcute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro.(n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?Endogenous Ligand for GPR120, Docosahexaenoic Acid, Exerts Benign Metabolic Effects on the Skeletal Muscles via AMP-activated Protein Kinase Pathway.Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men.Icosapent ethyl, a pure ethyl ester of eicosapentaenoic acid: effects on circulating markers of inflammation from the MARINE and ANCHOR studies.The effects of omega-3 polyunsaturated fatty acids and genetic variants on methylation levels of the interleukin-6 gene promoter.Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder.DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity.The differential effects of EPA and DHA on cardiovascular risk factors.Similarities and differences between the effects of EPA and DHA on markers of atherosclerosis in human subjects.The role of n - 6 and n - 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease.N-3 fatty acids for prevention of cardiovascular disease.Impact of anti-inflammatory nutrients on obesity-associated metabolic-inflammation from childhood through to adulthood.Role of Omega-3 Fatty Acids in the Etiology, Treatment, and Prevention of Depression: Current Status and Future Directions.Microalgae as healthy ingredients for functional food: a review.The essentials of essential fatty acids.Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients.The metabolic effects of omega-3 plant sterol esters in mixed hyperlipidemic subjects.No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.Personalized polyunsaturated fatty acids as a potential adjunctive treatment for anorexia nervosa.Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials.Docosahexaenoic acid and eicosapentaenoic acid reduce C-reactive protein expression and STAT3 activation in IL-6-treated HepG2 cells.
P2860
Q27686781-C4FBF158-84F3-42E5-9D1A-434522277988Q28075256-2EB9A06D-7724-423D-9102-092C988B7DB8Q28386437-465405FE-1C7F-451F-87BB-5EDFA60B8A8BQ33623946-D62A40EA-7F61-4A2E-88AF-844F04ADA9CCQ33666208-DBB5AB54-C8F6-42A8-9960-7ADB1D18F05CQ33901555-25A9B955-D7FA-4349-BB4D-E49B2D37E93CQ34145456-04C80E03-D247-4471-B083-E16D4A964102Q34292912-6FD6D235-52B0-43FC-B9E4-DD383FC0C613Q34344828-6F265596-792D-4E38-9F4C-32922E5CD7D9Q34411758-6B45D17A-8A1C-4913-BA5B-D6C2ED08EA2CQ34471990-2B79DC3B-89BA-4FDA-A106-753CFA86427EQ34489921-D9850573-BF80-4D3D-8E5B-8A70D72CC92BQ34493093-E68D37B2-5495-4C5E-B909-2AE3381B21ADQ34635830-39CCFD42-0949-4C3A-BB16-6D19B391891EQ34680900-F332F644-9A10-42AA-8203-301459FAE110Q35181235-439E6A56-F0C4-4C7D-AF81-8A57F119EED6Q35460381-737A8F4C-9FAD-4952-9069-D10FB7469A03Q35572556-0839497F-FC9A-440C-8614-B9C15C8F9D24Q35627326-50C7AD05-DCC5-46DD-9F26-57BDF71C7157Q35753222-16F53E93-9D76-48D6-8DAB-B9142287E283Q35953181-9F346FC8-6583-4945-B2DE-8468C6A7D3E7Q36127724-D8B6AABA-4864-42B6-8010-C17EF88F432AQ36609778-BFB89EF9-3FA4-42F2-8E3B-3E125DDB400FQ36834277-08354688-7113-4AC3-AF5A-0CB451A53091Q37414767-568A3375-E24B-45DB-AEDE-AEFB272529F4Q37671776-E17CF99F-5CA7-48DD-928B-70509A0BA4C7Q37846894-A3050C00-F325-4B15-897F-93E6045E8360Q37988638-0E32AC9F-BE5B-4745-BAE4-0DE73E146302Q38185266-1DE99B26-C4E6-4ACF-8105-2A24B4ACA2ECQ38248569-8D07DAE4-1E32-42BD-8729-F1FD5FE65A21Q38758088-1F2B1FD8-90DF-410D-AB6C-7F8634F01C2CQ38808320-7618D143-BDED-44A4-8817-51F5179036A3Q39417824-514780D2-8DB4-4548-8DB7-85AB45147407Q42720337-418F9A3F-39EC-4958-A115-9CF8BB25FCEFQ42878436-AF285860-C9CC-4260-98E0-82DEBEADC306Q42975248-8A7C7F68-D4A6-493C-820E-3086F6945387Q45186149-E8F762BD-E366-4751-BB2F-3C8B53A956A7Q46510047-E0E68FB8-8F36-4FDF-B7A8-78E6F1DD50D5Q48181231-B2A5C5F2-8FA0-4427-97A6-AD6AF34817BAQ54453208-034DD0C6-BB2B-4843-AC09-3C64D6E92E51
P2860
DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
DHA supplementation decreases ...... on in hypertriglyceridemic men
@ast
DHA supplementation decreases ...... on in hypertriglyceridemic men
@en
DHA supplementation decreases ...... on in hypertriglyceridemic men
@nl
type
label
DHA supplementation decreases ...... on in hypertriglyceridemic men
@ast
DHA supplementation decreases ...... on in hypertriglyceridemic men
@en
DHA supplementation decreases ...... on in hypertriglyceridemic men
@nl
prefLabel
DHA supplementation decreases ...... on in hypertriglyceridemic men
@ast
DHA supplementation decreases ...... on in hypertriglyceridemic men
@en
DHA supplementation decreases ...... on in hypertriglyceridemic men
@nl
P2093
P2860
P356
P1433
P1476
DHA supplementation decreases ...... on in hypertriglyceridemic men
@en
P2093
Bruce E Mackey
Darshan S Kelley
David Siegel
Dawn M Fedor
Yuriko Adkins
P2860
P304
P356
10.3945/JN.108.100354
P407
P577
2009-01-21T00:00:00Z